期刊文献+

肺鳞癌与人乳头瘤病毒相关性研究 被引量:2

The Studies on Human Papillomavirus Infection in Squamous Cancer of the Lung
下载PDF
导出
摘要 目的:了解肺鳞癌组织中人乳头瘤病毒存在情况,并分析人乳头瘤病毒与肺癌发生部位、性别因素、角化程度、吸烟因素的关系。方法:采用地高辛标记的DNA探针对肺癌组织进行原位杂交检测,同时结合临床资料分析多种因素的相关性。结果:肺鳞癌组织,鳞状上皮生化组织、粘膜慢性炎组织HPV检出率分别为48.4%,27.4%,5.6%,各组比较差异显著(P<0.01),中心型肺癌与周围型肺癌组织HPV检出率分别为50.6%和4.4%,两组比较差异显著(P<0.01)。男女两组HPV检出率分别为46.1%和54.3%,差异无显著性(P>0.05)。吸烟组HPV检出率为50.6%,非吸烟组为43.9%,差异不显著(P>0.05)。结论:肺癌组织中存在一定比例HPV感染,HPV感染与肺鳞癌关系密切,中心型肺癌与HPV感染密切相关,HPV感染与性别及吸烟因素未发现明显相关性。人乳头瘤病毒感染可能与肺癌发生发展有关。 Objective: To investigate the relationship between human papillomavirus (HPV) infection and lung cancer, observe the distribution of HPV-DNA in the tissue of lung cancer and to analyze the interrelationship among human papillomavirus, smoke, sex and the histological stage of lung cancer. Methods: Tissue of lung cancer was obtained by surgical resection or biopsy. The tissue specimens were detected by in situ hybridization techniques for human papillomavirus types 6B/11, 16, 18 and 31 using digoxingemin labelled DNA probe. The studies on the mechanisms involved in pulmonary carcinogenesis associated with HPV infection. Results: a, The positive sign was mainly located in the nuclei of the cells. The rate of 48.4% of squamous cell carcinomaoma, 27.4% of metaplasia and 5.6% of chronic inflammation tissue were positive for HPV-DNA by in situ hybridization (P〈0.01); b, The positive rate of HPV in the central type group and peripheral typecontrol group was 50.6% and 4.4%, respectively (P〈0.01). c. No significant difference in positive rate of HPV in smoke, sex and the histological stage of lung cancer were found in squamous cell carcinoma. Conclusion: The HPV-DNA is closely associated with squamous cell carcinoma of the lung, especially in the central type lung cancer. The correlationship between the HPV-DNA and smoke, the sex and the histological stage of lung cancer were not found.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2005年第17期966-968,共3页 Chinese Journal of Clinical Oncology
基金 全军医药卫生科研基金资助(编号:No96M107)
关键词 鳞癌 人乳头瘤病毒 Squamous cell carcinoma Human papillomavirus
  • 相关文献

参考文献12

  • 1Steckley SL, Pickworth WB, Haverkos HW. Cigarette smoking and cervical cancer: Part Ⅱ: a geographic variability study [J].Biomed Pharmacother, 2003, 57(2): 78-83.
  • 2Wen Cheng Y, Lee H. Environmental exposure and lung cancer among nonsmokers: an example of Taiwan Residents female lung cancer[l]. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev,2003, 21(1): 1-28.
  • 3Steenbergen RD, Kramer D, Braakhuis BJ, et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia[l]. J Natl Cancer Inst, 2004, 96(4): 294-305.
  • 4Syrjanen KJ. HPV infections and lung cancer [J]. J Clin Pathol,2002, 55(12): 885-891.
  • 5Lele SM, Pou AM, Ventura K, et al. Molecular events in the progression of recurrent respiratory papillomatosis tocarcinoma [J].Arch Pathol Lab Med, 2002, 126(10): 1184-1188.
  • 6Zafer E, Ergun MA, Alver G, et al. Detection and typing of human papillomavirus in non-small cell lung cancer[l]. Respiration,2004, 71(1): 88-90.
  • 7Chlou IIL, Wu MF, Liaw YC, et al. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan [J]. Cancer, 2003, 97 (6):1558-1563.
  • 8Boyle P, Leon ME, Maisonneuve P, et al. Cancer control in women. Update 200311]. IntJ Gynaecol Obstet, 2003, 83 Suppl 1:179-202.
  • 9Moore TO, Moore AY, Carrasco D, et al. Human papillomavirus, smoking, and cancer [J].J Cutan Med Surg, 2001, 5(4):323-328.
  • 10Boardman LA, Cooper AS, Clark M, et al. I-IPV, cervical neoplasia and smoking: knowledge among colposcopy patients[J]. J Reprod Med, 2004, 49(12): 965-972.

同被引文献28

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2周颖,张辉,谢永红,赵敏,沈彦.人乳头状瘤病毒感染、P53及缺氧诱导因子-1α蛋白表达与非小细胞肺癌的相关性[J].中国老年学杂志,2015,35(2):335-337. 被引量:4
  • 3Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005,55 : 74-108.
  • 4Giuliani L, Jaxmar T, Casadio C, et al. Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma. Imng Cancer, 2007,57 : 273-281.
  • 5Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med,2008,359:821-832.
  • 6Klein F, Amin Kotb WF, Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer,2009,65:13-18.
  • 7Joh J, Jenson AB, Moore GD, et al. Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol, 2010,89 : 222-226.
  • 8Kato T, Koriyama C, Khan N,et al. EGFR mutations and human papillomavirus in lung cancer. Lung Cancer, 2012,78 : 144-147.
  • 9Chung CH, Gillison ML. Human papillomavirus in head and neck cancer:its role in pathogenesis and clinical implications. Clin Cancer Res,2009,15:6758-6762.
  • 10Clavel CE. Nawrocki B, Bsseaux B. et al. Delection of human papillomavirus DNA in bronchopulmonary carcinomas by hybrid captureⅡ: a study of 185tumors. Cancer, 2000,88 : 1347-1352.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部